FDA Approves First Cancer Drug Under New Real Time Review Program

FDA Approves First Cancer Drug Under New Real Time Review Program

Source: 
CP Wire
snippet: 
  • Kisqali approved under Real Time Oncology Review Program
  • One of two new programs intended to make the development of cancer drugs more effecient
  • Approval came less than one month after submission